Amedisys (AMED) Misses Q3 EPS by 8c

November 3, 2016 5:03 PM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Amedisys (NASDAQ: AMED) reported Q3 EPS of $0.36, $0.08 worse than the analyst estimate of $0.44. Revenue for the quarter came in at $361.6 million versus the consensus estimate of $361.08 million.

For earnings history and earnings-related data on Amedisys (AMED) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment